|

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

RECRUITINGSponsored by Wake Forest University Health Sciences
Actively Recruiting
SponsorWake Forest University Health Sciences
Started2001-05-21
Est. completion2026-06
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT01890486

Summary

To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Exclusion Criteria:

Participation in any other treatment research protocol

Conditions11

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaCancerChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaGerm Cell NeoplasmsHodgkin's DiseaseImmunodeficiency DiseasesMultiple MyelomaMyelodysplastic Syndromes

Locations1 site

Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157
David Hurd, MD336-716-2843dhurd@wakehealth.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.